Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Eoghan Mulholland PhD FHEA

Colorectal Cancer Team Lead (GSK-OXFORD)

Research Overview

Eoghan is the CRC Team Lead for the GSK-OXFORD GO-PRECISE programme. Eoghan's work is exploring molecular and cellular mechanisms of colorectal cancer (CRC) initiation and progression. Eoghan is part of the CRC-STARS Consortium (CRUK) which focuses to accelerate translational research to pave the way for personalised bowel cancer treatments. His work brings together basic and clinical scientists at the forefront of CRC research to interrogate a suite of state-of-the art pre-clinical models.